The government may have strong arguments for denying AstraZeneca's demands, but they may be harder to sustain given the sector - high-growth life sciences; the company - Britain's largest by market ...

The decision to ditch the development of an existing facility in the Speke area of Liverpool comes at a time when Prime ...

Pharmaceutical company AstraZeneca on Friday cancelled a planned 450 million-pound ($560 million) investment in a vaccine ...

AstraZeneca has scrapped plans to invest £450m in expanding a vaccine manufacturing plant in Liverpool, blaming a reduction in government support. The pharmaceutical giant has announced its decision ...

Pharmaceutical company AstraZeneca has cancelled a planned 450 million-pound investment in a vaccine manufacturing plant in ...

The pharmaceutical giant says the new Labour government has offered less investment than their Conservative predecessors.

Among the first 10 drugs selected for price negotiations under the 2022 Inflation Reduction Act, cardiometabolic medications ...

AstraZeneca cancels £450m vaccine plant in UK after Government 'own goal' in blow to Rachel Reeves growth plan - The ...

-- AstraZeneca has shelved a plan to build a vaccine manufacturing plant in Speke, near Liverpool, valued at 450 million pounds ($558.7 million), after months of talks with British government ...

While the former Biden administration showcased the Inflation Reduction Act as a key victory in the fight over high drug ...

AstraZeneca’s manufacturing will-they-won’t-they within its home country has swung back firmly toward the ‘they won’t’ camp ...